BPC-157 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use
[2] Not to mention the potential unwanted side effects like nausea, constipation, bloating, and a concerningly low appetite make it hard to stick it out long-term
Heres what to consider if youre taking any of these common diabetes prescriptions: GLP-1 receptor agonists: Caffeine doesnt directly interact with GLP-1 receptor agonists such as Trulicity, Ozempic, or Wegovy, but similar to Mounjaro, it may exacerbate nausea or GI discomfort, Dr
Phentermine is generally very affordable, but GLP-1s are often expensive and not always covered by insurance, especially if youre using them solely for weight loss and not for diabetes
Oral and intranasal formulations exist but subcutaneous is the most clinically reliable route
Dermatol 39 (4), 366374